Home › Clinical Cases
Uveitic macular edema (UME) is the most common cause of vision loss in patients with uveitis, regardless of the anatomical type. The presence of UME has been shown to be associated with substantial More >>
The need to identify alternate molecular targets for the management of retinal vascular diseases has been highlighted by the proportion of patients who have either a suboptimal or lack of response to More >>
Optimization of visual outcomes for patients with retinal diseases continues to evolve, as improved imaging modalities, surgical devices, as well as emerging and newly approved therapeutic More >>
The advanced form of age-related macular degeneration (AMD), geographic atrophy (GA) leads to a progressive and irreversible loss of visual function. Genetic variants of several complement factor More >>
Diabetic macular edema (DME) is a leading cause of visual impairment. While treatment advances have improved the overall visual outcomes for most patients with DME, there continue to be unmet needs More >>
Significant visual and anatomic improvements through the integration of intravitreal anti-vascular endothelial growth factor (VEGF) therapies are well reported in the management of retinal and More >>
X-linked retinitis pigmentosa (XLRP) is a rare, inherited retinal disease that leads to gradual vision loss in boys and young men. Patients usually present with early-onset night blindness followed More >>
Intravitreal therapy has rapidly evolved to become a mainstay of treatment for many retinal diseases, and it offers many patients delayed or arrested disease progression and, in some, the possibility More >>
Prompt diagnosis and timely initiation of anti-vascular endothelial growth factor (VEGF) therapies are imperative for optimal visual acuity gains for patients with central or branch retinal vein More >>
Intravitreal anti–vascular endothelial growth factor (VEGF) therapy has revolutionized the management paradigm for patients with retinal vascular diseases, yet there is still an unmet need to address More >>